palladium chloride has been researched along with Leukemia L5178 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bouzyk, E; Fokt, I; Fuks, L; Kruszewski, M; Lewandowski, W; Oldak, T; Priebe, W; Samochocka, K | 1 |
1 other study(ies) available for palladium chloride and Leukemia L5178
Article | Year |
---|---|
Differential toxic effect of cis-platinum(II) and palladium(II) chlorides complexed with methyl 3,4-diamine-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside in mouse lymphoma cell lines differing in DSB and NER repair ability.
Topics: Animals; Chromosome Breakage; Cisplatin; Comet Assay; Cross-Linking Reagents; DNA Adducts; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Inhibitory Concentration 50; Leukemia L5178; Lymphoma; Methylglycosides; Mice; Organoplatinum Compounds; Palladium | 2003 |